If you take Ramipril for blood pressure management, you might want to check your medication.
The FDA has initiated a recall of 600,000 bottles of the widely used drug due to concerns about contamination. The issue stems from an ingredient sourced by an unregulated manufacturer in India, which failed to meet proper supplier verification standards. While the FDA considers the risk of harm to be low, they’ve opted to act cautiously.
The recall affects Ramipril capsules in 2.5 mg, 5 mg, and 10 mg doses. This medication is commonly prescribed to treat hypertension by relaxing blood vessels and reducing strain on the heart, often following a heart attack.
Although no adverse effects have been reported so far, it’s advised to dispose of any affected bottles. The recalled products, manufactured by Lupin Pharmaceuticals, come in bottles of 90, 100, or 150 pills with expiration dates up to July 2026.
